Curcumin Bioactive Substance to Prevent Diabetic Retinopathy Due to Diabetes Mellitus Complications: A Literature Review
Downloads
Diabetes Mellitus is characterized by hyperglycemia, and if it continues, the patients are at risk of having a macrovascular or microvascular complication. One of the most frequent microvascular complications is Diabetic Retinopathy, with a prevalence of 42.6%. Most of the blindness due to Diabetic Retinopathy is a permanent condition and cannot be treated, so prevention is vital in reducing this disease. This literature aimed at providing the recent information related to the effect of curcumin in preventing Diabetic Retinopathy from occurring in patients with Diabetes Mellitus and becoming a source of the latest product innovation in preventing this disease. The writing began by electronic database searching via Google Scholar, Science Direct, Medline, and Research Gate. Only articles in English were taken as a literature review with the following research variables, namely the decrease in ROS (Reactive Oxygen Species), the decline in inflammation, morphological changes in the retina, and reduction in levels of VEGF (Vascular Endothelial Growth Factor)which is an angiogenic factor. Twelve studies showed the following measurement results, namely five studies showed a significant result for giving curcumin extract to decrease ROS; ten studies showed that curcumin extract could significantly improve the morphology of the retina; four studies showed that curcumin extract could significantly help the anti-inflammation process, and four studies showed a significant reduction in VEGF levels. Based on twelve articles reviewed, curcumin can act as a bioactive substance in preventing Diabetic Retinopathy in Patients with Diabetes Mellitus.
Adrian, D. (2017). Pengaruh Anti-VEGF pada Diabetic Retinopathy. CDK-258, 44(1). Accessed from Cermin Dunia Kedokteran Journals
Aldebasi, Y.H., Salah, M.A., & Arshad, H.R. (2013). Therapeutic implications of curcumin in the prevention of Diabetic Retinopathy via modulation of antioxidant activity and genetic pathways (Review Article). Int J Physiol Pathophysiol Pharmacol, 5(4):194-202.
Deshpande, J., Shankarnarayanan, J., Bhanuprakash, R.G., Sreenivasa, R., & Vijaya, J. (2015). Soluble Curcumin in the Prevention of Diabetic Retinopathy via Modulation of Antioxidant Activity and Genetic Pathways – In Vivo Model. Advances in Ophthalmology & Visual System, 3(1): 00077.
Elvira & Ernes, E.S. (2019). Diabetic Retinopathy. CDK-274, 46(3). Accessed from Cermin Dunia Kedokteran Journals
Gupta, S.K., Binit, K., Tapas, C.N., Shyam, S.A., Renu, A., Puneet, A., Rohit, S., & Sushma S. (2011). Curcumin Prevents Experimental Diabetic Retinopathy in Rats Through Its Hypoglycemic, Antioxidant, and Anti-Inflammatory Mechanisms. Journal of Ocular Pharmacology and Therapeutics, 27(2):123-130. DOI: 10.1089/jop.2010.0123.
Hewlings, S.J., & Douglas S.K. (2017). Curcumin: A Review of Its' Effects on Human Health. Foods 2017; 6: 92. United States of America.
Huang, J., Quanyong, Y., Yao, C., Yi, L., Guoxu, X., Ji, Z., Tongtong, N., Yuhong, Y., Weijie, Z., Sicheng, Q., & Weifeng, L. (2020). Curcumin suppresses oxidative stress via regulation of ROS/NF-κB signaling pathway to protect retinal vascular endothelial cell in Diabetic Retinopathy. Endocrinology & Metabolism Ophthalmology. DOI:10.21203/rs.3.rs-27239/v1.
Jeenger, M.K., Shweta, S., Veera, G.Y., Naidu, Sistla, R., & Ashutosh, K. (2015). Curcumin: A Pleiotropic Phytonutrient in Diabetic Complications. Nutrition (2014), DOI: 10.1016/j.nut.2014.06.015.
Jung, K.Y., Kim, K.M., and Lim, S. (2014). Therapeutic Approaches for Preserving or Restoring Pancreatic β-Cell Function and Mass. Diabetes Metab J. 38: 426-36
Kementerian Kesehatan Republik Indonesia. (2018). Apa Itu Retinopati Diabetik?. Jakarta, Indonesia: Kemenkes RI. (Accessed on November 21, 2020)
Kementerian Kesehatan Republik Indonesia. (2018). Retinopati and Biochemistry. 2016;39:1196-1208. Diabetik: Pergeseran Paradigma Kebutaan pada Era Milenial. Jakarta, Indonesia: Kemenkes RI. (Accessed on November 21, 2020)
Kementerian Kesehatan Republik Indonesia. (2019). Hari Diabetes Sedunia Tahun 2018. Jakarta, Indonesia: Kemenkes RI. (Accessed on November 21, 2020)
Kowluru, R.A., & Mamta, K. (2007). Effects of curcumin onretinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond), 4(8). DOI:10.1186/1743-7075-4-8
Kumawat, M., Singh, I., Singh, N., Singh, V., & Kharb, S. (2012). Lipid Peroxidation and Lipid Profile in Type II Diabetes Mellitus. Webmed Central Biochemistry. 2012; 3(3) :WMC003147. Rohtak India.
Lee, R., Tien, Y., & Charumathi, S. (2015). Epidemiology of Diabetic Retinopathy, Diabetic Macular Edema and Related Vision Loss. Eye and Vision Singapore: BioMed Central. 2015; 2:17. DOI 10.1186/s40662-015-0026-2.
Li, J., Peipei, W., Jia, Y., Zhen, C., & Songping, Y. (2016). Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/CalmodulinDependent Protein Kinase II Activity in StreptozotocinInduced Diabetes. Journal of Cellular Physiology and Biochemistry, 2016;39:1196-1208. DOI: 10.1159/000447826.
Li, J., Peipei, W., Yanxia, Z., Zhen, C., Tianyan, S., Wensheng, L., & Songping, Y. (2015). Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca2 + /Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats. Journal of ocular pharmacology and therapeutics 31(9):555-62. DOI: 10.1089/jop.2015.0006.
Maugeri, A., Maria, G.M., Francesco, G., Manlio, V., Guido, B., Martina, B., & Antonella, A. (2018). Curcumin Modulates DNA Methyltransferase Functions in a Cellular Model of Diabetic Retinopathy. Journal of Oxydative Medicine and Cellular Longevity, 2018;1-12.
Panasea, A.F. (2014). Pengaruh Pemberian Ekstrak Curcuma Longa L terhadap Titer Interleukin-6 (IL-6) dan Gambaran Histologi Pankreas pada Tikus (Rattus Norvegicus) Model Diabetes Melitus Tipe 1. (Thesis, University of Brawijaya, Malang, Indonesia). Accessed from http:// repository.ub.ac.id/id/eprint/126912
Phillip J. (2013). Curcumin supplementation is shown to halt the progression of diabetes in prediabetics. Natural News. Truth Publishing International Ltd.
Platania, C.B.M., Annamaria, F., Francesca, L., Cateno, P., Federica, G., Giovanni, G., Gian, M.L., Salvatore, S., Filippo, D., & Claudio, B. (2018). Retinal Protective and Distribytion of Curcumin in Vitro and in Vivo. DOI: 10.3389/fphar.2018.00670.
Pradhan, D., Toffa, D., & Gitanjali, T. (2018). Pharmacognostic Evaluation of Curcumin on Diabetic Retinopathy in Alloxan-induced Diabetes through NFKB and Brn3a Related Mechanism. Pharmacogn J, 10(2): 324-332. DOI : 10.5530/pj.2018.2.56.
Ran, Z., Yueling, Z., Xiaoying, W., & Jingxue, M. (2019). Curcumin inhibits high glucose-induced inflammatory injury in human retinal pigment epithelial cells through the ROS-PI3K/AKT/mTOR signaling pathway. Molecular Medicine Reports, 2018;19:1024-1031. DOI: 10. 3892/m m r. 2018.9749.
Riskesdas. (2018). Badan Penelitian dan Pengembangan Kesehatan Kementerian RI tahun 2018. Jakarta, Indonesia: (Accessed on November 21, 2020)
Salem, N.A., Gamal, M.A., Mohamed, E., & Amanuel, T.T. (2012). Effects of Curcumin on Early Retinal Neuro-Degenerative Changes in Diabetic Albino Rats. Journal of American Science, 8(1).
Septadina, I.S. (2015). Perubahan Anatomi Bola Mata pada Penderita Diabetes Mellitus. MKS, Th. 47(2).
Simorangkir, H.A. (2020). Mikroenkapsulasi Kombinasi Curcumin pada Kunyit (Curcuma Longa) dan Epigallocatechin-3-Gallate (EGCG) pada Daun Teh Hijau (Camellia Sinensis): Inovasi Terapi Pencegahan Diabetik Retinopati pada Penderita Diabetes Melitus Tipe 2. Scientific Medical Journal, 1(2). DOI: https://doi.org/10.32734/scripta.v1i2.1234
Soewondo, P., Sidartawan, S., Ketut, S., Agung, P., Djoko, W.S., & Askandar, T. (2010). The Diabcare Asia 2008 Study - Outcomes on Control and Complications of Type 2 Diabetic Patients in Indonesia. The DiabCare Asia 2008 study, 19(4): 235-244.
Suyono, E.A., & Pandelaki, K. (2014). Diabetes Melitus di Indonesia. In: Suyono E.A. Buku ajar ilmu penyakit dalam Jilid III. Edisi ke-6. Jakarta: Interna Publishing; 19101919.
World Health Organization. (2016). WHO Global Report on Diabetes. Switzerland: WHO
World Health Organization. (2016). Global Report on Diabetes Executive Summary. Switzerland: WHO
Yang, F., Jinqiang, Y., Feng, K., Mei, L., Dekun, L., Ke, T., Jiaojiao, L., Ying, W., Kaili, W., & Dai, L. (2018). Curcumin Alleviates Diabetic Retinopathy in Experimental Diabetic Rats. Ophtalmic Research, 60(1):43-54. DOI: 10.1159/000486574.
Zhang, D., Min, F., Si-Hua, G., & Jun-Li, L. (2013). Curcumin and Diabetes: A Systematic Review. Beijing, China: Evidence-Based Complementary and Alternative Medicine. Hindawi Publishing Vol 2013: 1-16.
Zhou, Y., Tiantian, Z., Xiaofei, W., Xiaowei, W., Yizhu, C., Lingyu, G., Junfeng, Z., & Changqian, W. (2015). Curcumin Modulates Macrophage Polarization Through the Inhibition of the Toll-Like Receptor 4 Expression and its Signaling Pathways. Cell Physiol Biochem, 36, 631-641. DOI: 10.1159/000430126.
Zuo, Z.F., Qiang, Z., & Xue-Zheng, L. (2013). Protective Effect of Curcumin on Retinal Muller Cell in Early Diabetic Rat. International Journal Opthalmol, 2013;6(4):422-424. DOI:10.3980/j.issn.2222-3959.2013.04.02.
- MEDIA GIZI INDONESIA Journal is the copyright owner of all materials published on this website.
- The formal legal provisions for access to digital articles of this electronic journal are subject to the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license (CC BY-NC-SA 4.0), which means that MEDIA GIZI INDONESIA Journal and readers reserve the right to save, transmit media / format, manage in database, maintain, and publish articles as long as it continues to include the name of the Author.
- Printed and published print and electronic manuscripts are open access for educational, research and library purposes. In addition to these objectives, the editorial board shall not be liable for violations of copyright law.